Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Connect Biopharma Holdings (CNTB) Revenue (2024 - 2025)

Connect Biopharma Holdings' Revenue history spans 2 years, with the latest figure at $16000.0 for Q3 2025.

  • For Q3 2025, Revenue fell 98.69% year-over-year to $16000.0; the TTM value through Sep 2025 reached $714000.0, down 41.43%, while the annual FY2024 figure was $26.0 million, N/A changed from the prior year.
  • Revenue for Q3 2025 was $16000.0 at Connect Biopharma Holdings, down from $698000.0 in the prior quarter.
  • Across five years, Revenue topped out at $1.2 million in Q3 2024 and bottomed at $16000.0 in Q3 2025.